Conversely, IFN-I signaling in tumor cells has been shown to upregulate indoleamine-2,3-dioxygenase 1 (IDO1) after radiation, which contributed to radiation resistance and inhibition of immune responses in tumors (73). This evidence concerns the gene IDO1 and neoplasm.